Literature DB >> 19836978

Risk factors for valproic acid resistance in childhood absence epilepsy.

May Lissa Ollivier1, Marie France Dubois, Maja Krajinovic, Patrick Cossette, Lionel Carmant.   

Abstract

AIMS: Valproic acid (VPA) is reported to be effective for the control of absence seizures in 75% of children. The aim of this study was to determine the clinical and socio-demographic factors associated with VPA response in newly diagnosed childhood absence epilepsy (CAE) and to determine if these factors also influence the chances of achieving long-term seizure freedom.
METHODS: Medical charts of 180 children with CAE were retrospectively reviewed. Clinical, electroencephalographic and imaging findings were recorded to correlate with complete VPA response and long-term epilepsy outcome. Factors associated with non-responsiveness were identified individually and in a multivariable logistic regression analysis.
RESULTS: Treatment was successful in 112 (58.3%) children. More children that were non-responsive to VPA experienced generalized tonic clonic seizures (GTCS) (33.8% vs. 13.4% for responders; p=0.001) and 52.9% had a pre-treatment seizure frequency greater than 10/day (vs. 27.0% for responders; p<0.001). Finally, responders were older at time of diagnosis versus non-responders (p=0.001). Absence of long-term seizure freedom was linked to the presence of GTCS, the absence of initial response and the need for multiple AEDs to control seizures.
INTERPRETATION: Our results suggest that clinical phenotypes are associated with reduced response rates to VPA. This should be taken into account when counselling families of children with newly diagnosed absence epilepsy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19836978     DOI: 10.1016/j.seizure.2009.09.007

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  5 in total

1.  Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats.

Authors:  V D'Amore; I Santolini; C M van Rijn; F Biagioni; G Molinaro; A Prete; P J Conn; C W Lindsley; Y Zhou; P N Vinson; A L Rodriguez; C K Jones; S R Stauffer; F Nicoletti; G van Luijtelaar; R T Ngomba
Journal:  Neuropharmacology       Date:  2012-06-15       Impact factor: 5.250

2.  Seizure control in patients with idiopathic generalized epilepsies: EEG determinants of medication response.

Authors:  Jerzy P Szaflarski; Christopher J Lindsell; Tarek Zakaria; Christi Banks; Michael D Privitera
Journal:  Epilepsy Behav       Date:  2010-03-12       Impact factor: 2.937

3.  Transplantation of GABAergic Interneurons into the Neonatal Primary Visual Cortex Reduces Absence Seizures in Stargazer Mice.

Authors:  Mohamed Hammad; Stephen L Schmidt; Xuying Zhang; Ryan Bray; Flavio Frohlich; H Troy Ghashghaei
Journal:  Cereb Cortex       Date:  2014-05-08       Impact factor: 5.357

4.  Amantadine for the Treatment of Refractory Absence Seizures in Children.

Authors:  Mini Sreedharan; Kalpana Devadathan; Habib K Pathan; Shiji Chalipat; Kunju P A Mohammed
Journal:  J Pediatr Neurosci       Date:  2018 Apr-Jun

5.  Predictors of Outcome in Juvenile Myoclonic Epilepsy.

Authors:  Yiqian Chen; Jingzhen Chen; Xingyu Chen; Ru Wang; Jianqi Zeng; Feng Wang; Jiayin Miao
Journal:  Risk Manag Healthc Policy       Date:  2020-06-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.